UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 10-Q

              [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                  For the Quarterly Period Ended March 31, 2001

                                       OR

              [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                       For the transaction period from      to
                                                       ----    ----

                        Commission File Number  000-18799
                                               -----------


                       HEALTH MANAGEMENT ASSOCIATES, INC.
     ----------------------------------------------------------------------
             (Exact name of Registrant as specified in its charter)

          DELAWARE                                         61-0963645
--------------------------------                 ----------------------------
  (State or other jurisdiction                          (I.R.S. Employer
of incorporation or organization)                     Identification Number)

   5811 Pelican Bay Boulevard, Suite 500, Naples, Florida         34108-2710
---------------------------------------------------------       --------------
       (Address of principal executive offices)                   (Zip Code)

                                    (941)598-3131
                 ----------------------------------------------------
               (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months, and (2) has been subject to such filing requirements
for the past 90 days.

                                                             Yes  X   No
                                                                 ---     ---

At May 4, 2001, the following shares of the Registrant were outstanding:

                  Class A Common Stock               245,071,639 shares





                       HEALTH MANAGEMENT ASSOCIATES, INC.
                                    FORM 10-Q

                  FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2001

                                      INDEX
                                      -----

PART I.  FINANCIAL INFORMATION                                              Page

Item 1.  Financial Statements

         Consolidated Statements of Income--
           Three Months Ended March 31, 2001 and 2000 ......................   3

         Consolidated Statements of Income--
           Six Months Ended March 31, 2001 and 2000 ........................   4

         Condensed Consolidated Balance Sheets--
           March 31, 2001 and September 30, 2000 ...........................   5

         Condensed Consolidated Statements of Cash Flows--
           Six Months Ended March 31, 2001 and 2000 ........................   6

         Notes to Interim Condensed Consolidated Financial Statements ...... 7-8

Item 2.  Management's Discussion and Analysis of Financial
                  Condition and Results of Operations ....................  9-13

PART II. OTHER INFORMATION ............................................... 14-15

Signatures ...............................................................    16

Index To Exhibits ........................................................ 17-18




                                       2


PART I.  FINANCIAL INFORMATION
Item 1.  Financial Statements

                       HEALTH MANAGEMENT ASSOCIATES, INC.

                        CONSOLIDATED STATEMENTS OF INCOME
                    (In thousands, except per share amounts)
                                   (Unaudited)




                                                             Three months ended
                                                                 March 31,
                                                           ---------------------
                                                             2001         2000
                                                           --------     --------
                                                                  
Net patient service revenue ..........................     $481,144     $408,655

Costs and expenses:
   Salaries and benefits .............................      177,520      143,179
   Supplies and other ................................      135,666      115,183
   Provision for doubtful accounts ...................       33,051       32,885
   Depreciation and amortization .....................       22,116       18,534
   Rent expense ......................................       10,254        9,268
   Interest, net .....................................        5,272        6,503
   Non-cash charge for retirement benefits
     and write down of assets held for sale ..........       17,000         --
                                                           --------     --------
       Total costs and expenses ......................      400,879      325,552
                                                           --------     --------


Income before income taxes ...........................       80,265       83,103

Provision for income taxes ...........................       31,525       32,616
                                                           --------     --------


Net income ...........................................     $ 48,740     $ 50,487
                                                           ========     ========


Net income per share:
   Basic .............................................     $    .20     $    .21
                                                           ========     ========
   Diluted ...........................................     $    .19     $    .21
                                                           ========     ========


Weighted average number of shares outstanding:

   Basic .............................................      244,117      241,064
                                                           ========     ========
   Diluted ...........................................      263,100      244,979
                                                           ========     ========





                             See accompanying notes.




                                       3


                       HEALTH MANAGEMENT ASSOCIATES, INC.

                        CONSOLIDATED STATEMENTS OF INCOME
                    (In thousands, except per share amounts)
                                   (Unaudited)



                                                             Six months ended
                                                                 March 31,
                                                           ---------------------
                                                             2001         2000
                                                           --------     --------
                                                                  
Net patient service revenue ..........................     $915,381     $778,749

Costs and expenses:
   Salaries and benefits .............................      346,673      279,607
   Supplies and other ................................      261,735      225,129
   Provision for doubtful accounts ...................       68,956       67,058
   Depreciation and amortization .....................       43,546       36,666
   Rent expense ......................................       19,776       18,542
   Interest, net .....................................       11,308       12,193
   Non-cash charge for retirement benefits
     and write down of assets held for sale ..........       17,000         --
                                                           --------     --------
       Total costs and expenses ......................      768,994      639,195
                                                           --------     --------


Income before income taxes ...........................      146,387      139,554

Provision for income taxes ...........................       57,469       54,775
                                                           --------     --------


Net income ...........................................     $ 88,918     $ 84,779
                                                           ========     ========



Net income per share:
   Basic .............................................     $    .36     $    .35
                                                           ========     ========
   Diluted ...........................................     $    .35     $    .35
                                                           ========     ========


Weighted average number of shares outstanding:

   Basic .............................................      243,671      241,492
                                                           ========     ========
   Diluted ...........................................      263,689      244,863
                                                           ========     ========







                             See accompanying notes.







                                       4


                       HEALTH MANAGEMENT ASSOCIATES, INC.

                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (In thousands)

                                     ASSETS
                                     ------



                                                          March 31,    September 30,
                                                            2001           2000
                                                         -----------   -------------
                                                         (Unaudited)
                                                                 
Current assets:
  Cash and cash equivalents ..........................   $    41,548    $    16,471
  Receivables--net ...................................       392,505        372,653
  Supplies, prepaids and other assets ................        66,554         57,866
  Funds held by trustee ..............................         2,818          2,562
  Deferred income taxes ..............................        37,411         37,411
                                                         -----------    -----------
       Total current assets ..........................       540,836        486,963

Property, plant and equipment ........................     1,393,889      1,352,819
  Less accumulated depreciation and amortization .....      (324,855)      (287,489)
                                                         -----------    -----------
       Net property, plant and equipment .............     1,069,034      1,065,330

Other assets:
  Funds held by trustee ..............................         1,944          2,005
  Excess of cost over acquired net assets, net .......       206,833        195,004
  Deferred charges and other assets ..................        19,932         22,763
                                                         -----------    -----------
       Total .........................................       228,709        219,772
                                                         -----------    -----------

                                                         $ 1,838,579    $ 1,772,065
                                                         ===========    ===========

                  LIABILITIES AND STOCKHOLDERS' EQUITY
                  ------------------------------------

Current liabilities:
  Accounts payable ...................................   $    87,340    $    78,227
  Accrued expenses and other liabilities .............        77,600         82,910
  Income taxes--currently payable and deferred .......         4,285          2,122
  Current maturities of long-term debt ...............         6,619          6,523
                                                         -----------    -----------
       Total current liabilities .....................       175,844        169,782

Deferred income taxes ................................        27,896         34,496
Other long-term liabilities ..........................        31,747         17,570
Long-term debt .......................................       464,940        520,151

Stockholders' equity:
  Preferred stock, $.01 par value, 5,000
    shares authorized ................................          --             --
  Common stock, Class A, $.01 par value, 750,000
    shares authorized, 257,471 and 255,357
    shares issued and outstanding at March 31,
    2001 and September 30, 2000, respectively ........         2,575          2,554
  Additional paid-in capital .........................       327,981        308,834
  Retained earnings ..................................       919,087        830,169
                                                         -----------    -----------
                                                           1,249,643      1,141,557
  Less treasury stock, 12,500 shares at cost .........      (111,491)      (111,491)
                                                         -----------    -----------
       Total stockholders' equity ....................     1,138,152      1,030,066
                                                         -----------    -----------

                                                         $ 1,838,579    $ 1,772,065
                                                         ===========    ===========




                             See accompanying notes.




                                       5


                       HEALTH MANAGEMENT ASSOCIATES, INC.

                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (In thousands)
                                   (Unaudited)



                                                           Six months ended
                                                               March 31,
                                                        ----------------------
                                                          2001          2000
                                                        ---------    ---------
                                                               
Cash flows from operating activities:
  Net income ........................................   $  88,918    $  84,779
  Adjustments to reconcile net income to net
   cash provided by operating activities:
     Depreciation and amortization ..................      43,546       36,666
     Provision for doubtful accounts ................      68,956       67,058
     Loss on sale of fixed assets ...................          10           16
     Charges for retirement benefits
       and write down of assets held for sale .......      17,000         --

     Changes in assets and liabilities:
       Receivables ..................................     (88,827)     (93,495)
       Supplies and other current assets ............      (8,688)      (9,133)
       Deferred charges and other assets ............      (5,569)      (6,943)
       Accounts payable .............................       9,113        2,873
       Accrued expenses and other liabilities .......      (5,219)       3,148
       Income taxes--
         currently payable and deferred .............       2,163      (12,511)
       Other long term liabilities ..................      (6,363)         477
                                                        ---------    ---------

          Net cash provided by operating activities .     115,040       72,935
                                                        ---------    ---------

Cash flows from investing activities:
  Additions to property, plant and equipment ........     (53,737)     (56,442)
  Proceeds from sale of property, plant and equipment       2,929          148
                                                        ---------    ---------

          Net cash used in investing activities .....     (50,808)     (56,294)
                                                        ---------    ---------

Cash flows from financing activities:
  Proceeds from long-term borrowings ................       5,314       47,810
  Principal payments on debt ........................     (63,442)     (11,449)
  (Increase) decrease in funds held by trustee ......        (195)         763
  Purchases of treasury stock .......................        --        (42,399)
  Proceeds from issuance of common stock ............      19,168          108
                                                        ---------    ---------

          Net cash used in financing activities .....     (39,155)      (5,167)
                                                        ---------    ---------

                Net increase in cash ................      25,077       11,474

Cash and cash equivalents at beginning of period ....      16,471       12,926
                                                        ---------    ---------

Cash and cash equivalents at end of period ..........   $  41,548    $  24,400
                                                        =========    =========



                             See accompanying notes.





                                       6


                       HEALTH MANAGEMENT ASSOCIATES, INC.
          NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.  Basis of Presentation
-------------------------

     The condensed consolidated balance sheet as of September 30, 2000 has been
derived from the audited consolidated financial statements included in Health
Management Associates, Inc.'s (the Company's) 2000 Annual Report. The interim
condensed consolidated financial statements at March 31, 2001 and for the three
and six month periods ended March 31, 2001 and 2000 are unaudited; however, such
interim statements reflect all adjustments (consisting only of a normal
recurring nature) which are, in the opinion of management, necessary for a fair
presentation of the financial position and results of operations for the interim
periods presented. The results of operations for the interim periods presented
are not necessarily indicative of the results to be expected for the full year.
The interim financial statements should be read in conjunction with the audited
consolidated financial statements of the Company included in its 2000 Annual
Report.

2.   Use of Estimates
---------------------

     The preparation of financial statements in conformity with generally
accepted accounting principles requires management of the Company to make
estimates and assumptions that affect the amounts reported in the condensed
consolidated financial statements. Actual results could differ from the
estimates.

3.  Earnings Per Share
----------------------

     The following table sets forth the computation of basic and diluted
earnings per share (in thousands, except per share data):



                                        Three months ended      Six months ended
                                             March 31,              March 31,
                                        -------------------   -------------------
                                          2001       2000       2001        2000
                                        --------   --------   --------   --------
                                                             
 Numerator:
   Numerator for basic earnings per
    share-net income ................   $ 48,740   $ 50,487   $ 88,918   $ 84,779
   Effect of convertible debt .......      1,337       --        2,673       --
                                        --------   --------   --------   --------
   Numerator for diluted earnings
    per share .......................   $ 50,077   $ 50,487   $ 91,591   $ 84,779
                                        ========   ========   ========   ========

Denominator:
   Denominator for basic earnings
    per share-weighted average shares    244,117    241,064    243,671    241,492
   Effect of dilutive securities:
    Employee stock options ..........      4,534      3,915      5,569      3,371
    Convertible debt ................     14,449       --       14,449       --
                                        --------   --------   --------   --------
   Denominator for diluted earnings
    per share .......................    263,100    244,979    263,689    244,863
                                        ========   ========   ========   ========

Basic earnings per share ............   $    .20   $    .21   $    .36   $    .35
                                        ========   ========   ========   ========
Diluted earnings per share ..........   $    .19   $    .21   $    .35   $    .35
                                        ========   ========   ========   ========



                                       7


                       HEALTH MANAGEMENT ASSOCIATES, INC.
          NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

4.  Non-Cash Charge
-------------------

     The non-cash charge for retirement benefits and write down of assets held
for sale represents (1) the present value of the future costs of retirement
benefits granted to the Company's chairman pursuant to an employment agreement
which became effective January 2, 2001, and (2) the write down of two hospital
assets held for sale subsequent to their respective replacement.


                                       8


Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations

         Results of Operations
         ---------------------
         Three months ended March 31, 2001 compared
         ------------------------------------------
         to three months ended March 31, 2000
         ------------------------------------

              Net patient service revenue for the three months ended March 31,
         2001 ("2001 Period") was $481.1 million as compared to $408.7 million
         for the three months ended March 31, 2000 ("2000 Period"). This
         represented an increase in net patient service revenue of $72.4 million
         or 17.7%. Hospitals in operation for the entire 2001 Period and 2000
         Period ("same hospitals") provided $31.4 million of the increase in net
         patient service revenue, resulting from patient volume increases. The
         remaining increase of $41.0 million included $43.0 million of net
         patient service revenue from the July 2000 acquisition of a 268-bed
         hospital, the September 2000 acquisition of a 120-bed hospital and the
         October 2000 acquisition of a 149-bed hospital, offset by a decrease of
         $2.0 million in Corporate and other revenue.

              During the 2001 Period the Company's hospitals generated total
         patient days of service and an occupancy rate of 238,835 and 52.8%,
         respectively, versus 213,763 and 50.4%, respectively, for the 2000
         Period. Same hospital patient days and occupancy for the 2001 Period
         were 206,644 and 52.6%, respectively, versus 201,018 and 50.5%,
         respectively for the 2000 Period. Same hospital admissions for the
         Company during the 2001 Period were 44,942, up 5.3% from the 42,669
         admissions during the 2000 Period.

              The Company's operating expenses (salaries and benefits, supplies
         and other, provision for doubtful accounts and rent expense) for the
         2001 Period were $356.5 million or 74.1% of net patient service revenue
         as compared to $300.5 million or 73.5% of net patient service revenue
         for the 2000 Period. Of the total $56.0 million increase, approximately
         $20.0 million related to same hospitals, which was largely attributable
         to increased patient volumes. Another $35.5 million of increased
         operating expense related to the acquisitions mentioned previously. The
         remaining increase of $.5 million represented the net increase in
         Corporate and other operating expenses.

              The Company's depreciation and amortization costs increased by
         $3.6 million and interest expense decreased by $1.2 million. The
         increase in depreciation and amortization resulted primarily from the
         acquisitions mentioned previously. The decrease in interest expense was
         due to improved interest rates on borrowings and increased investment
         income (which is netted against interest expense) in the 2001 period.
         The non-cash charge for retirement benefits and write down of assets
         held for sale represents (1) the present value of the future costs of
         retirement benefits granted to the Company's chairman pursuant to an
         employment agreement which became effective January 2, 2001, and (2)
         the write down of two hospital assets held for sale subsequent to their
         respective replacement.


                                       9


Item 2.  Management's discussion and Analysis of Financial
         Condition and Results of Operations (continued)


              The Company's income before income taxes was $80.3 million for the
         2001 Period. Excluding the non-recurring charge for retirement benefits
         and write down of assets held for sale of $17.0 million, income before
         income taxes was $97.3 million for the 2001 Period as compared to $83.1
         million for the 2000 Period, an increase of $14.2 million or 17.1%. The
         increase resulted primarily from same hospital volume increases and the
         acquisitions mentioned previously. The Company's provision for income
         taxes was $31.5 million for the 2001 Period as compared to $32.6
         million for the 2000 Period. These provisions reflect effective income
         tax rates of approximately 39.3% for both periods. As a result of the
         foregoing, the Company's net income was $48.7 million for the 2001
         Period including the aforementioned charge, and $59.1 million for the
         2001 Period excluding the charge, as compared to $50.5 million for the
         2000 Period.

         Results of Operations
         ---------------------
         Six months ended March 31, 2001 compared
         ----------------------------------------
         to six months ended March 31, 2000
         ----------------------------------

              Net patient service revenue for the six months ended March 31,
         2001 ("2001 Six Month Period") was $915.4 million, as compared to
         $778.7 million for the six months ended March 31, 2000 ("2000 Six Month
         Period"). This represented an increase in net patient service revenue
         of $136.7 million, or 17.6%. Same hospitals provided $56.6 million of
         the increase in net patient service revenue, resulting from patient
         volume increases. The remaining increase of $80.1 million included
         $82.5 million of net patient service revenue from the acquisitions
         mentioned previously, offset by a decrease of $2.4 million in Corporate
         and other revenue.

              During the 2001 Six Month Period the Company's hospitals generated
         448,266 total patient days of service and an occupancy rate of 49.0%,
         respectively, versus 408,023 and 47.8%, respectively, for the 2000 Six
         Month Period. Same hospital patient days and occupancy for the 2001 Six
         Month Period were 384,769 and 48.4%, respectively, versus 378,782 and
         47.3%, respectively, for the 2000 Six Month Period. Same hospital
         admissions for the Company during the 2001 Six Month Period were 85,177
         up 4.3% from the 81,690 admissions during the 2000 Six Month Period.

              The Company's operating expenses (salaries and benefits, supplies
         and other, provision for doubtful accounts and rent expense) for the
         2001 Six Month Period were $697.1 million, or 76.2% of net patient
         service revenue as compared to $590.3 million or 75.8% of net patient
         service revenue for the 2000 Six Month Period. Of the total $106.8
         million increase, approximately $37.8 million related to same
         hospitals, which was largely attributable to increased patient volumes.
         Another $68.1 million of increased operating expenses related to the
         hospital acquisitions mentioned previously. The remaining increase of
         $.9 million represented the net increase in Corporate and other
         operating expenses.


                                       10


Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations (Continued)

              The Company's depreciation and amortization costs increased by
         $6.9 million and interest expense decreased by $.9 million. The
         increase in depreciation and amortization resulted primarily from the
         acquisitions previously mentioned. The decrease in interest expense was
         due to improved interest rates on borrowings and increased investment
         income (which is netted against interest expense) in the 2001 Six Month
         Period. The non-cash charge for retirement benefits and write down of
         assets held for sale represents (1) the present value of the future
         costs of retirement benefits granted to the Company's chairman pursuant
         to an employment agreement which became effective January 2, 2001, and
         (2) the write down of two hospital assets held for sale subsequent to
         their respective replacement.

              The Company's income before income taxes was $146.4 million for
         the 2001 Six Month Period. Excluding the non-recurring charge for
         retirement benefits and write down of assets held for sale of $17.0
         million, income before income taxes was $163.4 for the 2001 Six Month
         Period as compared to $139.6 million for the 2000 Six Month Period, an
         increase of $23.8 million, or 17.0%. The increase resulted primarily
         from same hospital volume increases and the acquisitions mentioned
         previously. The Company's provision for income taxes was $57.5 million
         for the 2001 Six Month Period as compared to $54.8 million for the 2000
         Six Month Period. These provisions reflect effective income tax rates
         of approximately 39.3% for both periods. As a result of the foregoing,
         the Company's net income was $88.9 million for the 2001 Six Month
         Period including the aforementioned charge, and $99.2 for the 2001 Six
         Month Period excluding the charge, as compared to $84.8 million for the
         2000 Six Month Period.

         Liquidity and Capital Resources
         -------------------------------

              2001 Six Month Period Cash Flows compared to 2000 Six Month Period
         Cash Flows

              The Company's operating cash flows totaled $115.0 million for the
         2001 Six Month Period as compared to $72.9 million for the 2000 Six
         Month Period. The continued positive cash flows from operating
         activities results from the Company's profitability and management of
         its working capital. The Company's investing activities used $50.8
         million and $56.3 million for the 2001 Six Month Period and 2000 Six
         Month Period, respectively. Construction costs related to the
         replacement of existing hospitals accounted for the majority of the
         expenditures in the 2000 Six Month Period while ongoing renovation and
         capital equipment costs accounted for the majority of the expenditures
         in the 2001 Six Month Period. Financing activities used net cash of
         $39.2 million for the 2001 Six Month Period and $5.2 million for the
         2000 Six Month Period. Increased principal payments on debt offset by
         proceeds from the issuance of common stock accounted for the majority
         of net cash used in the 2001 Six Month Period, while borrowings used
         primarily to finance the purchase of treasury stock accounted for the
         net cash used in the 2000 Six Month Period. See the Condensed
         Consolidated Statements of Cash Flows for the six months ended March
         31, 2001 and 2000 at page 6 of this Report.


                                       11


Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations (Continued)



         Capital Resources

              The Company currently has a 5-year $450 million Credit Agreement
         (the "Credit Agreement") due November 30, 2004. The Credit Agreement is
         a term loan agreement which permits the Company to borrow under an
         unsecured revolving credit loan at any time through November 30, 2004,
         at which time the agreement terminates and all outstanding amounts
         become due and payable. The Company may choose a Base Rate Loan (prime
         interest rate) or a Eurodollar Rate Loan (LIBOR interest rate). The
         interest rate for a Eurodollar Rate Loan is currently LIBOR plus 1.00
         percent (6.06% at March 31, 2001), and will increase or decrease in
         relation to a change in the Company's credit rating. Under either
         alternative, quarterly interest payments are required. As of March 31,
         2001, the outstanding balance was $80 million.

              The Company also has a $15 million unsecured revolving credit
         commitment with a bank. The $15 million credit is a working capital
         commitment which is tied to the Company's cash management system, and
         renews annually on November 1. Currently, interest on any outstanding
         balance is payable monthly at a fluctuating rate not to exceed the
         bank's prime rate less .25%. As of March 31, 2001, there were no
         amounts outstanding under this credit commitment.

              On August 16, 2000, the Company sold $488.8 million face value of
         zero-coupon convertible senior subordinated debentures for gross
         proceeds of $287.7 million. The debentures mature on August 16, 2020
         unless converted or redeemed earlier. The debentures are convertible
         into the Company's class A common stock at a conversion rate of 29.5623
         shares for each $1,000 principal amount of debentures converted
         (equivalent to a conversion price of $19.9125 per share). Interest on
         the debentures is payable in arrears on August 16 and February 16 of
         each year, beginning February 16, 2001 at a rate of .25% per year on
         the principal amount due at maturity. The rate of cash interest and
         accrual of original issue discount represent a yield to maturity of 3%
         per year, calculated from August 16, 2000. The Company used the net
         proceeds generated from the sale and issuance of the debentures to pay
         down borrowings under its revolving credit facility.

              Neither the debentures nor the shares of class A common stock
         underlying the debentures were registered or required to be registered
         under the Securities Act of 1933 and were sold in the United States in
         a private placement under Rule 144A of the Securities Act. Pursuant to
         a Registration Rights Agreement with the holders of the debentures, the
         Company registered the debentures and the underlying class A common
         stock for resale under the Securities Act pursuant to a registration
         statement on Form S-3, which registration statement became effective
         with the Securities and Exchange Commission on January 17, 2001.


                                       12


Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations (Continued)


         Forward-Looking Statements
         --------------------------

              Certain statements contained in this Form 10-Q, including, without
         limitation, statements containing the words "believes," "anticipates,"
         "intends," " expects" and words of similar import, constitute
         "forward-looking statements" within the meaning of the Private
         Securities Litigation Reform Act of 1995. Such forward-looking
         statements involve known and unknown risks, uncertainties and other
         factors that may cause the actual results, performance or achievements
         of the Company or industry results to be materially different from any
         future results, performance or achievements expressed or implied by
         such forward-looking statements. Such factors include, among others,
         the following: general economic and business conditions, both
         nationally and in the regions in which the Company operates; industry
         capacity; demographic changes; existing governmental regulations and
         changes in, or the failure to comply with, governmental regulations;
         legislative proposals for health care reform; the ability to enter into
         managed care proposals for health care reform; the ability to enter
         into Medicare and Medicaid payment levels; liability and other claims
         asserted against the Company; competition; the loss of any significant
         ability to attract and retain qualified personnel, including
         physicians; the availability and terms of capital to fund additional
         acquisitions or replacement facilities. Given these uncertainties,
         prospective investors are cautioned not to place undue reliance on such
         forward-looking statements. The Company disclaims any obligation to
         update any such factors or to publicly announce the results of any
         revision to any of the forward-looking statements contained herein to
         reflect future events or developments.


                                       13


                           PART II - OTHER INFORMATION


Item 1.  Legal Proceedings.
         -----------------

         None.


Item 2.  Changes in Securities.
         ---------------------

         None.


Item 3.  Defaults upon Senior Securities.
         -------------------------------

         None.


Item 4.  Submission of Matters to a Vote of Security Holders.
         ---------------------------------------------------

         At the Annual Meeting of Stockholders of the Company on February 20,
         2001, the stockholders of the Company adopted proposals to:

         a) elect seven directors of the Company



                                               Votes For         Withheld
                                               ----------        ----------
                                                           
            William J. Schoen                  210,450,829       2,818,891
            Kent P. Dauten                     210,394,530       2,875,190
            Robert A. Knox                     210,394,230       2,875,490
            Charles R. Lees                    210,394,280       2,875,440
            Kenneth D. Lewis                   210,394,530       2,875,190
            William E. Mayberry, M.D.          210,394,530       2,875,190
            Randolph W. Westerfield, Ph.D.     210,394,530       2,875,190


         b) approve and ratify the selection of Ernst & Young LLP as
            the Company's independent auditors for the fiscal year
            ending September 30, 2001 (213,098,772 votes for; 61,174
            votes against; 109,774 votes abstained)

Item 5.  Other Information.
         -----------------

         None.


Item 6.  Exhibits and Reports on Form 8-K.
         --------------------------------

         a. Exhibits:
            --------

            See Index to Exhibits located on page 17.


                                       14


                     PART II - OTHER INFORMATION (continued)



Item 6.  Exhibits and Reports on Form 8-K. (continued)
         ---------------------------------

         b. Reports on Form 8-K:
            -------------------

            Form 8-K Reporting Date--March 9, 2001
                     Item Reported--Item 5. Other Events and Regulation FD
                     Disclosure. The Company filed Form 8-K to announce (a) the
                     promotion of Mr. Robert E. Farnham to Senior Vice President
                     and Chief Financial Officer and (b) the retirement of Mr.
                     Stephen M. Ray, Executive Vice President and Chief
                     Financial Officer.





                                       15


                                   SIGNATURES

          Pursuant to the requirements of the securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                         HEALTH MANAGEMENT ASSOCIATES, INC.




DATE:  May 7, 2001                       BY:   /s/ Robert E. Farnham
                                              ------------------------------
                                              Robert E. Farnham
                                              Senior Vice President-Finance
                                              (Duly authorized officer and
                                              Principal Financial Officer)






                                       16


                                INDEX TO EXHIBITS


(2)   Plan of acquisition, reorganization, arrangement, liquidation or
      succession.

      Not applicable.

(3)  (i)  Articles of Incorporation
     3.1  The Fifth Restated Certificate of Incorporation, previously
          filed and included as Exhibit 3.1 to the Company's Quarterly
          Report on Form 10-Q for the quarter ended March 31, 1995, is
          incorporated herein by reference.

     3.2  Certificate of Amendment to Fifth Restated Certificate of
          Incorporation, previously filed and included as Exhibit 3.2
          to the Company's Annual Report on Form 10-K for the year
          ended September 30, 1999, is incorporated herein by
          reference.

     (ii) By-laws
          The By-laws, as amended are filed as part of this Report as Exhibit
          3.3 at page 19 hereof.

(4)  Instruments defining the rights of security holders, including indentures.

     The Exhibits referenced under (3) of this Index to Exhibits are
     incorporated herein by reference.

     Credit Agreement by and among Health Management Associates, Inc., as
     Borrower, Bank of America, N.A., as Administrative Agent and as Lender,
     First Union National Bank, as Syndication Agent and as Lender, and the
     Chase Manhattan Bank, as Syndication Agent and as Lender, and The Lenders
     Party Hereto From Time To Time, dated November 30, 1999, previously filed
     and included as Exhibit 4.5 to the Company's Annual Report on Form 10-K for
     the fiscal year ended September 30, 1999, is incorporated herein by
     reference.

     Credit Agreement dated March 23, 2000 between First Union National Bank and
     Health Management Associates, Inc., pertaining to a $15 million working
     capital and cash management line of credit, previously filed and included
     as Exhibit 4.1 to the Company's Quarterly Report on Form 10-Q for the
     quarter ended March 31, 2000, is incorporated herein by reference.

(10) Material contracts.

     Employment Agreement for William J. Schoen dated January 2, 2001,
     previously filed and included as Exhibit 99.2 to the Company's Registration
     Statement Form S-8 as filed on January 12, 2001 is incorporated herein by
     reference.


                                       17


                          INDEX TO EXHIBITS (Continued)



(11) Statement re computation of per share earnings.

     Not applicable.

(15) Letter re unaudited interim financial information.

     Not applicable.

(18) Letter re change in accounting principles.

     Not applicable.

(19) Report furnished to security holders.

     Not applicable.

(22) Published report regarding matters submitted to vote of security holders.

     Not applicable.

(23) Consents of experts and counsel.

     Not applicable.

(24) Power of attorney.

     Not applicable.

(99) Additional exhibits.

     Not applicable.
                                       18